Affiliation:
1. Singapore Management University , Singapore & Institutet för Näringslivsforskning, Sweden
Abstract
Abstract
This article examines pricing in pharmaceutical markets where branded products face competition from generics. After providing evidence for brand premia and switching costs using prescription-level and matched socioeconomic data for the entire Swedish population, I estimate a dynamic oligopoly model and evaluate counterfactual policies that reduce the impact of frictions on pricing. Lengthening the procurement period reduces the impact of switching costs on prices. The policy increases prices on average, but more so for individuals with infrequent consumption, high education and income. In a counterfactual where brand choice decisions are moved from patients to medical experts, prices fall substantially.
Funder
Universidad Carlos III de Madrid
University of Gothenburg
Northwestern University
University College London
University of Bern
National University of Singapore
University of Sydney
University of Melbourne
Publisher
Oxford University Press (OUP)
Subject
Economics and Econometrics
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献